Back to Hematology
Hematologyv2014Evidence-Based

HScore for Reactive Hemophagocytic Syndrome

Estimates the risk of having reactive hemophagocytic syndrome (RHS) based on clinical, laboratory, and histologic findings. Uses nine variables to provide a probability score ranging from <1% to >99% for RHS diagnosis.

Clinical Input Parameters

mg/dL
mg/dL
ng/mL
IU/L
Clinical Assessment
Awaiting Parameters
hscore
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The HScore for Reactive Hemophagocytic Syndrome is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within hematology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

HScore = sum of weighted points from 9 variables: immunosuppression (0-18), temperature (0-49), organomegaly (0-38), cytopenias (0-34), triglycerides (0-64), fibrinogen (0-30), ferritin (0-50), AST (0-19), hemophagocytosis (0-35)

Clinical Pearls & Practice Notes

  • Developed from multicenter retrospective cohort of 312 patients
  • Validates across adult and pediatric populations
  • Does not replace clinical judgment or bone marrow biopsy when indicated
  • Should be used in conjunction with expert hematology consultation
  • Reactive hemophagocytic syndrome is a life-threatening condition requiring urgent treatment
  • Original online calculator available at http://saintantoine.aphp.fr/score/
  • Differential diagnosis includes sepsis and hematologic malignancies

Evidence & Literature Citations

  1. Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hie M. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2613-20.
  2. Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, Corazza F. Performances of the HScore in the diagnosis of hemophagocytic lymphohistiocytosis: a multicenter study. J Clin Med. 2021 May 17;10(10):2143.

Score Interpretation Ranges

Very Low Risk0 – 90 pts

HScore ≤90

Low Risk91 – 168 pts

HScore 91-168

Intermediate Risk169 – 250 pts

HScore 169-250

High Risk251 – 337 pts

HScore >250

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.